187 related articles for article (PubMed ID: 14767645)
1. Gelatinase expression in ocular surface disorders.
Sakimoto T; Shoji J; Kanno H; Sawa M
Jpn J Ophthalmol; 2004; 48(1):17-22. PubMed ID: 14767645
[TBL] [Abstract][Full Text] [Related]
2. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
Ottino P; He J; Axelrad TW; Bazan HE
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):487-96. PubMed ID: 15671273
[TBL] [Abstract][Full Text] [Related]
3. Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas.
Inaki N; Tsunezuka Y; Kawakami K; Sato H; Takino T; Oda M; Watanabe G
J Heart Lung Transplant; 2004 Feb; 23(2):218-27. PubMed ID: 14761770
[TBL] [Abstract][Full Text] [Related]
4. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.
Forsyth PA; Wong H; Laing TD; Rewcastle NB; Morris DG; Muzik H; Leco KJ; Johnston RN; Brasher PM; Sutherland G; Edwards DR
Br J Cancer; 1999 Apr; 79(11-12):1828-35. PubMed ID: 10206300
[TBL] [Abstract][Full Text] [Related]
5. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
[TBL] [Abstract][Full Text] [Related]
7. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas.
Ye HQ; Maeda M; Yu FS; Azar DT
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2894-9. PubMed ID: 10967042
[TBL] [Abstract][Full Text] [Related]
9. Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in normal and keratoconus corneas.
Collier SA; Madigan MC; Penfold PL
Curr Eye Res; 2000 Aug; 21(2):662-8. PubMed ID: 11148603
[TBL] [Abstract][Full Text] [Related]
10. Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis.
Zhang H; Li C; Baciu PC
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):955-62. PubMed ID: 11923234
[TBL] [Abstract][Full Text] [Related]
11. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
Jo M; Thomas LE; Wheeler SE; Curry TE
Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206
[TBL] [Abstract][Full Text] [Related]
12. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
[TBL] [Abstract][Full Text] [Related]
13. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
Luo L; Li DQ; Doshi A; Farley W; Corrales RM; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4293-301. PubMed ID: 15557435
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of matrix metalloproteinases in the murine zymosan-induced multiple organ dysfunction syndrome.
Volman TJ; Goris RJ; Lomme RM; DeGroot J; Verhofstad AA; Hendriks T
J Pathol; 2004 Aug; 203(4):968-75. PubMed ID: 15259001
[TBL] [Abstract][Full Text] [Related]
15. Augmented membrane type 1 matrix metalloproteinase (MT1-MMP):MMP-2 messenger RNA ratio in gastric carcinomas with poor prognosis.
Caenazzo C; Onisto M; Sartor L; Scalerta R; Giraldo A; Nitti D; Garbisa S
Clin Cancer Res; 1998 Sep; 4(9):2179-86. PubMed ID: 9748137
[TBL] [Abstract][Full Text] [Related]
16. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.
Davidson B; Goldberg I; Berner A; Nesland JM; Givant-Horwitz V; Bryne M; Risberg B; Kristensen GB; Tropé CG; Kopolovic J; Reich R
Am J Clin Pathol; 2001 Apr; 115(4):517-24. PubMed ID: 11293899
[TBL] [Abstract][Full Text] [Related]
17. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea.
Afonso AA; Sobrin L; Monroy DC; Selzer M; Lokeshwar B; Pflugfelder SC
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2506-12. PubMed ID: 10509643
[TBL] [Abstract][Full Text] [Related]
18. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).
Fukushima K; Nakamura A; Ueda H; Yuasa K; Yoshida K; Takeda S; Ikeda S
BMC Musculoskelet Disord; 2007 Jun; 8():54. PubMed ID: 17598883
[TBL] [Abstract][Full Text] [Related]
19. Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers.
Dogru M; Asano-Kato N; Tanaka M; Igarashi A; Shimmura S; Shimazaki J; Okada N; Takano Y; Fukagawa K; Tsubota K; Fujishima H
Curr Eye Res; 2005 Oct; 30(10):897-908. PubMed ID: 16251127
[TBL] [Abstract][Full Text] [Related]
20. Active form of gelatinases in tear fluidin patients with corneal ulcer or ocular burn.
Sakimoto T; Shoji J; Sawa M
Jpn J Ophthalmol; 2003; 47(5):423-6. PubMed ID: 12967855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
